SCHEMBL340541

SCHEMBL340541

O=CC(=O)C(c1ccccc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.54
TDP1 Q9NUW8 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
CTSD P07339 1/20 0.50
POLB P06746 1/20 0.48
SRC P12931 1/20 0.48
MAPK1 P28482 2/20 0.46
LMNA P02545 2/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9213321 0.81 CYP2D6 (0.50) CYP2D6TDP1L3MBTL1HDAC3HDAC4
SCHEMBL28683531 0.81 LMNA (0.60) CYP2D6TDP1L3MBTL1HDAC3HDAC4
SCHEMBL15287194 0.80 ALDH1A1 (0.49) CYP2D6TDP1L3MBTL1HDAC3HDAC4
SCHEMBL27378799 0.79 CYP2D6 (0.48) CYP2D6TDP1L3MBTL1HDAC3HDAC4
SCHEMBL15389025 0.79 PTGS2 (0.48) CYP2D6TDP1L3MBTL1HDAC3HDAC4
SCHEMBL29065182 0.79 SRC (0.67) CYP2D6TDP1L3MBTL1HDAC3HDAC4
SCHEMBL13517797 0.78 TDP1 (0.52) CYP2D6TDP1L3MBTL1HDAC3HDAC4
SCHEMBL18533251 0.78 CPN1 (0.47) TDP1L3MBTL1HDAC4HDAC7HDAC5
SCHEMBL17599982 0.76 TDP1 (0.45) CYP2D6TDP1L3MBTL1HDAC3HDAC4
SCHEMBL8814507 0.76 TDP1 (0.50) CYP2D6TDP1L3MBTL1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6987197-B2 Organozirconium composite and method of synthesizing the same, raw material solution containing the same, and method of forming lead zirconate titanate thin film MITSUBISHI MATERIALS CORPORATION (JP) 2006-01-17 US claimed
US-20040034245-A1 Organozirconium composite and method of synthesizing the same, raw material solution containing the same, and method of forming lead zirconate titanate thin film MITSUBISHI MATERIALS CORPORATION (JP) 2004-02-19 US claimed
US-6248928-B1 REACTING STRONTIUM WITH A STERICALLY HINDERED ALCOHOL TO PRODUCE STRONTIUM ALKOXIDE; REACTING THE STRONTIUM ALKOXIDE WITH A BETA-DIKETONE TO FORM A STRONTIUM BETA-DIKETONATE ALCOHOL ADDUCT AND REMOVING THE ALCOHOL INORGTECH LIMITED (GB) 2001-06-19 US claimed
EP-3719617-B1 MULTIFUNCTIONAL PEN MITSUBISHI PENCIL CO (JP) 2023-08-16 EP disclosed
US-20230192692-A1 MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF TIANJIN NORMAL UNIVERSITY (CN) 2023-06-22 US disclosed
US-11221686-B2 Multifunction pen MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2022-01-11 US disclosed
CN-113075346-A Gas chromatography separation analysis method based on aromatic macrocycle, molecular cage and pillar quinone and application 天津师范大学 2021-07-06 CN disclosed
US-20200363881-A1 MULTIFUNCTION PEN MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2020-11-19 US disclosed
EP-3719617-A1 MULTIFUNCTIONAL PEN Mitsubishi Pencil Company, Limited (JP) 2020-10-07 EP disclosed
CN-111386512-A Multifunctional pen 三菱铅笔株式会社 2020-07-07 CN disclosed
CN-110642684-A Macrocyclic and cage-shaped molecules based on biphenyl arene and derivative compounds thereof, and synthetic method and application thereof 天津师范大学 2020-01-03 CN disclosed
WO-2016198784-A1 THERMOCHROMIC MAKEUP OR TATTOOING MICROCAPSULES AND COMPOSITION INK AND OUT SAS (FR) 2016-12-15 WO disclosed
US-8616797-B2 Thermosensitive decolorable ink composition MITSUBISHI PENCIL COMPANY, LTD. (JP) 2013-12-31 US disclosed
EP-2412762-A1 THERMOSENSITIVE DECOLORABLE INK COMPOSITION Mitsubishi Pencil Company, Limited (JP) 2012-02-01 EP disclosed
US-20120014740-A1 THERMOSENSITIVE DECOLORABLE INK COMPOSITION MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2012-01-19 US disclosed
US-6987197-B2 Organozirconium composite and method of synthesizing the same, raw material solution containing the same, and method of forming lead zirconate titanate thin film MITSUBISHI MATERIALS CORPORATION (JP) 2006-01-17 US disclosed
US-20040034245-A1 Organozirconium composite and method of synthesizing the same, raw material solution containing the same, and method of forming lead zirconate titanate thin film MITSUBISHI MATERIALS CORPORATION (JP) 2004-02-19 US disclosed
US-6248928-B1 REACTING STRONTIUM WITH A STERICALLY HINDERED ALCOHOL TO PRODUCE STRONTIUM ALKOXIDE; REACTING THE STRONTIUM ALKOXIDE WITH A BETA-DIKETONE TO FORM A STRONTIUM BETA-DIKETONATE ALCOHOL ADDUCT AND REMOVING THE ALCOHOL INORGTECH LIMITED (GB) 2001-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192692-A1 MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF TPMT, NUDT1, PNP CYP2D6 785/4885TDP1 1238/4885L3MBTL1 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.